Livingston's Valneva vaccine shows 'strong immune response'


7/4/2021 16:58:00
Print
     Photo Credit: GETTY IMAGES

A Covid vaccine being manufactured in Scotland has reported a 90% immune response in early trials.

 

Biotech company Valneva tested its vaccine on 153 people and concluded it was safe and generally well tolerated.

 

The company will move to phase three by testing up to 5,000 people, some of whom will be recruited in Scotland.

 

UK Health Secretary Matt Hancock said if approved, the vaccine would play an "important role" in protecting communities.

 

Valneva, which manufactures its Covid vaccine at a plant in Livingston, said the results of their phase one/two study showed the vaccine was "highly immunogenic with more than 90% of all study participants developing significant levels of antibodies" to the Covid virus spike protein.

 

Those who received a medium dose of the vaccine showed an 89.8% immune response, while people given a high dose showed a 100% response.

 

The vaccine also induced T-cell responses, which help the body fend off a virus and play a role in long-lasting immunity.

 

No safety concerns were identified by an independent data safety monitoring board.

 

 

PUKmedia / BBC


 

Kurdish woman stabbed to death by her husband in France


A 36-year-old woman in France was stabbed to death and the country's police arrested her husband on charges of murder.

 

"On the morning of 31-3-2021, a man was arrested on cha...


»  UK activists commemorate Halabja tragedy
»  Kurdish politician competes to enter the German parliament

 

UNICEF calls on world governments to bring students back to schools


The United Nations International Children's Emergency Fund (UNICEF) launched a campaign to bring students back to school, warning that education suffers from a global crisis due to the covid pandem...


»  Will new US administration change its policy towards Syrian Kurds?
»  Consequences of Kurdistan’s oil dependent economy

Caricature